Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. Kourti
PROGNOSTIC FACTORS (PFs) IN PRIMARY MEDIASTINAL LARGE B-Cell LYMPHOMA (PMLBCL) TREATED WITH RITUXIMAB-CHOP (RCHOP) ± RADIOTHERAPY (RT)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Primary Mediastinal Large B-Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and CHOP
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Pd-1 Inhibitor Plus Chemotherapy in Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (Pmlbcl) With Aggressive Bulky Disease
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Primary Mediastinal Large B-Cell Lymphoma During Pregnancy
Case Reports in Hematology
First-Line Adjuvant Radiotherapy Improves PFS in Primary Mediastinal Large B-Cell Lymphoma - A Retrospective Analysis of 102 Patients From a Single Center
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Primary Mediastinal Large B-Cell Lymphoma-The Role of Mediastinal Radiation
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Tumor Necrosis as a Prognostic Factor of Diffuse Large B-Cell Lymphoma Treated With R-Chop Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop
British Journal of Haematology
Hematology
Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
